CD73-IN-18
Product Specifications
UNSPSC Description
CD73-IN-18 (compound 35j) is an orally available inhibitor of extracellular 5-nucleotidase (CD73). CD73-IN-18 can be used in anti-cancer research[1].
Target Antigen
CD73
Type
Reference compound
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cd73-in-18.html
Smiles
O=C(C(C1=CC(NCCC2=CC=CC=C2)=C(N=N1)C3=COC=C3)=CN4)NC4=O
Molecular Weight
375.38
References & Citations
[1]Xu Y, et al. Discovery of Novel 5-(Pyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione Derivatives as Potent and Orally Bioavailable Inhibitors Targeting Ecto-5'-nucleotidase. J Med Chem. 2024 Oct 10.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-169189/CD73-IN-18-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-169189/
Clinical Information
No Development Reported
CAS Number
3037968-61-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items